Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Anderson

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Allergy and Clinical Immunology|October 9, 2017
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapyFaye A H Cooles, Amy E Anderson, Dennis W Lendrem, et al.
Helicobacter|February 21, 2007
Helicobacter infection in the surfactant protein D-deficient mouseWafa Khamri, Mulugeta L Worku, Amy E Anderson, et al.
Immunology|October 25, 2022
Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patientsGemma Vidal-Pedrola, Najib Naamane, James A Cameron, et al.
Journal of Leukocyte Biology|April 24, 2008
Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cellsAmy E Anderson, Bethan L Sayers, Muzlifah A Haniffa, et al.
Frontiers in Immunology|February 13, 2023
Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerationsKristian C Williams, Abigail Gault, Amy E Anderson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2021
Pim Kinases as Therapeutic Targets in Early Rheumatoid ArthritisNicola J Maney, Henrique Lemos, Ben Barron-Millar, et al.
Frontiers in Immunology|June 6, 2018
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid ArthritisFaye A H Cooles, Amy E Anderson, Andrew Skelton, et al.
Arthritis Research & Therapy|December 21, 2016
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapiesFaye A H Cooles, Amy E Anderson, Tracey Drayton, et al.
Drug and Alcohol Review|June 1, 2021
Predictors of alcohol use during pregnancy in Australian womenTracey W Tsang, Melanie Kingsland, Emma Doherty, et al.
Journal of Frailty, Sarcopenia and Falls|March 6, 2023
The Rheumatoid Arthritis and MUScle (RAMUS) Study: Protocol for an observational single-arm study of skeletal muscle in patients with rheumatoid arthritis receiving tofacitinibJoshua L Bennett, Maha Egail, Amy E Anderson, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Allergy and Clinical Immunology|October 9, 2017
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapyFaye A H Cooles, Amy E Anderson, Dennis W Lendrem, et al.
Helicobacter|February 21, 2007
Helicobacter infection in the surfactant protein D-deficient mouseWafa Khamri, Mulugeta L Worku, Amy E Anderson, et al.
Immunology|October 25, 2022
Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patientsGemma Vidal-Pedrola, Najib Naamane, James A Cameron, et al.
Journal of Leukocyte Biology|April 24, 2008
Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cellsAmy E Anderson, Bethan L Sayers, Muzlifah A Haniffa, et al.
Frontiers in Immunology|February 13, 2023
Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerationsKristian C Williams, Abigail Gault, Amy E Anderson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2021
Pim Kinases as Therapeutic Targets in Early Rheumatoid ArthritisNicola J Maney, Henrique Lemos, Ben Barron-Millar, et al.
Frontiers in Immunology|June 6, 2018
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid ArthritisFaye A H Cooles, Amy E Anderson, Andrew Skelton, et al.
Arthritis Research & Therapy|December 21, 2016
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapiesFaye A H Cooles, Amy E Anderson, Tracey Drayton, et al.
Drug and Alcohol Review|June 1, 2021
Predictors of alcohol use during pregnancy in Australian womenTracey W Tsang, Melanie Kingsland, Emma Doherty, et al.
Journal of Frailty, Sarcopenia and Falls|March 6, 2023
The Rheumatoid Arthritis and MUScle (RAMUS) Study: Protocol for an observational single-arm study of skeletal muscle in patients with rheumatoid arthritis receiving tofacitinibJoshua L Bennett, Maha Egail, Amy E Anderson, et al.
Pageof 8